0,943  0,001  Antiparkinsonian, rigidity relieving
0,911  0,002  Muscle relaxant
0,888  0,002  Skeletal muscle relaxant
0,851  0,002  Dopamine D2 agonist
0,821  0,005  Respiratory analeptic
0,809  0,003  5 Hydroxytryptamine release stimulant
0,803  0,003  Dopamine agonist
0,780  0,005  Antidepressant
0,766  0,003  5 Hydroxytryptamine 7 antagonist
0,762  0,002  Dopamine D1 antagonist
0,760  0,006  Mood disorders treatment
0,745  0,004  Dopamine antagonist
0,734  0,004  5 Hydroxytryptamine antagonist
0,716  0,003  Alpha 2 adrenoreceptor antagonist
0,716  0,007  Antiparkinsonian
0,704  0,004  Dopamine D2 antagonist
0,694  0,004  5 Hydroxytryptamine 2 antagonist
0,688  0,008  Analeptic
0,676  0,003  Dopamine D5 antagonist
0,668  0,003  Sigma receptor agonist
0,667  0,003  5 Hydroxytryptamine 2A antagonist
0,668  0,010  Antipsychotic
0,644  0,005  Cardiodepressant
0,637  0,004  Alpha adrenoreceptor antagonist
0,632  0,005  CYP2D6 inhibitor
0,628  0,004  Male reproductive disfunction treatment
0,596  0,004  5 Hydroxytryptamine 1 antagonist
0,595  0,004  Erectile dysfunction treatment
0,599  0,013  Spasmolytic
0,582  0,004  5 Hydroxytryptamine 1A antagonist
0,605  0,028  CYP3A4 substrate
0,561  0,004  Alpha 2b adrenoreceptor antagonist
0,563  0,017  CYP1A2 substrate
0,548  0,004  Alpha 2a adrenoreceptor antagonist
0,530  0,003  Dopamine D3 antagonist
0,532  0,020  CYP2D6 substrate
0,529  0,020  Histamine release inhibitor
0,552  0,044  Caspase 9 stimulant
0,521  0,019  CYP2C19 inhibitor
0,509  0,010  Psychostimulant
0,530  0,031  CYP2C9 substrate
0,518  0,029  Prostate cancer treatment
0,490  0,004  Alpha 2c adrenoreceptor antagonist
0,476  0,005  Cholinergic antagonist
0,476  0,005  Acetylcholine antagonist
0,473  0,004  Antiparkinsonian, tremor relieving
0,487  0,028  Anxiolytic
0,502  0,044  Transcription factor NF kappa B inhibitor
0,469  0,014  Vasodilator
0,520  0,068  Apoptosis agonist
0,468  0,018  Hypoxia-inducible factor 1 alpha inhibitor
0,469  0,025  Caspase 3 stimulant
0,490  0,047  Antineoplastic (lung cancer)
0,454  0,014  Sedative
0,449  0,015  Antineoplastic enhancer
0,439  0,007  Antiadrenergic
0,431  0,005  Tyrosine 3 hydroxylase inhibitor
0,432  0,007  5 Hydroxytryptamine 2B antagonist
0,443  0,018  Dependence treatment
0,447  0,031  Hepatic disorders treatment
0,418  0,004  5 Hydroxytryptamine 1E antagonist
0,450  0,042  Cognition disorders treatment
0,415  0,008  Adrenaline antagonist
0,456  0,049  Antileukemic
0,418  0,014  Cyclic AMP phosphodiesterase inhibitor
0,408  0,005  5 Hydroxytryptamine 1F antagonist
0,407  0,005  Acetylcholine M1 receptor antagonist
0,400  0,005  Antitussive
0,390  0,003  5 Hydroxytryptamine 5A antagonist
0,389  0,005  5 Hydroxytryptamine agonist
0,393  0,009  Pneumotoxic
0,380  0,005  Acetylcholine nicotinic antagonist
0,385  0,013  Antineoplastic (squamous cell carcinoma)
0,375  0,003  Restless leg syndrome treatment
0,417  0,050  Vasodilator, peripheral
0,384  0,019  Anesthetic general
0,372  0,007  Neurotrophic factor enhancer
0,378  0,018  P-glycoprotein inhibitor
0,400  0,040  Antihypertensive
0,384  0,032  DNA damaging
0,353  0,008  Toxic, respiratory center
0,353  0,013  Cholinergic
0,409  0,071  15-Lipoxygenase inhibitor
0,343  0,006  Acetylcholine muscarinic antagonist
0,350  0,013  Topoisomerase II inhibitor
0,343  0,009  Alpha 1 adrenoreceptor antagonist
0,337  0,004  5 Hydroxytryptamine 5 antagonist
0,335  0,005  Opioid kappa receptor antagonist
0,355  0,024  Abortion inducer
0,371  0,041  CYP3A4 inhibitor
0,327  0,005  Neuronal nicotinic receptor antagonist
0,313  0,010  Topoisomerase I inhibitor
0,317  0,015  Genotoxic
0,359  0,063  Antineoplastic (colorectal cancer)
0,354  0,060  Antineoplastic (colon cancer)
0,316  0,025  Hepatoprotectant
0,292  0,003  Antineoplastic alkaloid
0,378  0,094  Analgesic
0,293  0,009  Alpha 1a adrenoreceptor antagonist
0,372  0,089  Antineoplastic (breast cancer)
0,287  0,011  CDC-like kinase 1 inhibitor
0,283  0,009  Antismoking
0,274  0,005  5 Hydroxytryptamine 1B antagonist
0,297  0,028  Antimigraine
0,279  0,012  LDLR expression enhancer
0,311  0,047  Antineoplastic (liver cancer)
0,276  0,015  Antiviral (Hepatitis B)
0,275  0,016  Acetylcholinesterase inhibitor
0,338  0,084  Stroke treatment
0,266  0,012  Uterine stimulant
0,277  0,026  Antiseptic
0,296  0,045  Mutagenic
0,310  0,059  Antihypercholesterolemic
0,300  0,050  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,252  0,004  Alpha 2 adrenoreceptor agonist
0,256  0,008  5 Hydroxytryptamine 1 agonist
0,333  0,089  Prostaglandin dehydrogenase inhibitor
0,285  0,042  Antiarrhythmic
0,247  0,004  Antiviral (Papilloma)
0,246  0,005  Acetylcholine M4 receptor antagonist
0,243  0,005  Phosphodiesterase V inhibitor
0,241  0,005  Prolactin inhibitor
0,249  0,016  5 Hydroxytryptamine 3E antagonist
0,304  0,075  Antineoplastic (small cell lung cancer)
0,246  0,018  Carcinogenic, group 1
0,233  0,006  Female sexual dysfunction treatment
0,277  0,054  Antineoplastic (glioblastoma multiforme)
0,227  0,005  CDC-like kinase 3 inhibitor
0,293  0,072  Antineoplastic (melanoma)
0,228  0,010  Calcium antagonist
0,221  0,004  Phosphodiesterase 11A inhibitor
0,221  0,004  Phosphodiesterase XI inhibitor
0,256  0,041  Antialcoholic
0,220  0,004  Nicotinic receptor alpha7 subunit antagonist
0,283  0,067  UGT1A9 substrate
0,244  0,029  Antiischemic, cerebral
0,270  0,056  Pyruvate kinase inhibitor
0,221  0,008  5 Hydroxytryptamine 1A agonist
0,219  0,007  Alpha adrenoreceptor agonist
0,223  0,011  Opioid antagonist
0,222  0,011  Dopamine D4 antagonist
0,230  0,019  DNA intercalator
0,215  0,005  Phosphodiesterase 5A inhibitor
0,261  0,053  Anticonvulsant
0,264  0,062  Antineoplastic (lymphoma)
0,233  0,031  Liver fibrosis treatment
0,204  0,004  Nicotinic alpha4beta2 receptor antagonist
0,263  0,064  Acute neurologic disorders treatment
0,233  0,035  Antineoplastic (carcinoma)
0,200  0,003  Dopamine D1 agonist
0,263  0,066  Dyrk kinase inhibitor
0,265  0,069  Antineoplastic (glioma)
0,202  0,006  Dopamine uptake inhibitor
0,265  0,069  Antipyretic
0,217  0,022  Alkylator
0,203  0,009  Opioid mu receptor antagonist
0,272  0,079  Antihypoxic
0,272  0,080  CYP2C19 substrate
0,213  0,028  ATPase inhibitor
0,212  0,029  Anesthetic local
0,259  0,076  Flavin-containing monooxygenase substrate
0,249  0,067  DNA synthesis inhibitor
0,250  0,067  Sensitization
0,186  0,004  5 Hydroxytryptamine 2 agonist
0,267  0,087  FMO3 substrate
0,197  0,018  5 Hydroxytryptamine 2C antagonist
0,205  0,027  Psychosexual dysfunction treatment
0,262  0,085  Radioprotector
0,264  0,089  Cardioprotectant
0,177  0,009  Sigma receptor antagonist
0,170  0,004  5 Hydroxytryptamine 3B antagonist
0,233  0,067  Antimitotic
0,181  0,016  Breast cancer-resistant protein inhibitor
0,179  0,017  Alpha 1b adrenoreceptor antagonist
0,170  0,012  Analgesic, opioid
0,165  0,010  5 Hydroxytryptamine 1D antagonist
0,163  0,010  Acetylcholine M2 receptor antagonist
0,158  0,006  Opioid mu receptor agonist
0,191  0,040  Tubulin antagonist
0,260  0,109  Antineoplastic (brain cancer)
0,154  0,002  Prolactin release inhibitor
0,168  0,016  Opioid delta receptor antagonist
0,154  0,009  Alpha 1 adrenoreceptor agonist
0,150  0,006  Opioid kappa receptor agonist
0,147  0,007  Opioid agonist
0,140  0,004  Nicotinic alpha3beta2 receptor antagonist
0,149  0,015  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,166  0,034  Antiprotozoal (Amoeba)
0,228  0,097  Cardiotonic
0,143  0,015  Alpha 1d adrenoreceptor antagonist
0,255  0,129  Vasodilator, coronary
0,133  0,007  5 Hydroxytryptamine 2A agonist
0,154  0,029  Constipation treatment
0,126  0,004  Dopamine autoreceptor agonist
0,126  0,005  5 Hydroxytryptamine 1B agonist
0,152  0,033  Butyrylcholinesterase inhibitor
0,212  0,099  Tumour necrosis factor alpha release inhibitor
0,300  0,188  Antineoplastic (solid tumors)
0,219  0,109  Antineoplastic (ovarian cancer)
0,122  0,014  Acetylcholine M3 receptor antagonist
0,251  0,146  Calcium channel activator
0,110  0,005  5 Hydroxytryptamine 7 agonist
0,125  0,021  Phosphodiesterase 6D inhibitor
0,246  0,143  Antiprotozoal (Plasmodium)
0,108  0,005  5 Hydroxytryptamine 4 antagonist
0,165  0,063  UGT2B9 substrate
0,110  0,009  Nicotinic receptor alpha3 subunit antagonist
0,205  0,103  Antineoplastic (non-small cell lung cancer)
0,126  0,024  Acetylcholine nicotinic agonist
0,223  0,123  Antiischemic
0,157  0,058  Anesthetic
0,105  0,007  Nicotinic receptor alpha4 subunit antagonist
0,194  0,097  Teratogen
0,110  0,015  Acetylcholine M5 receptor antagonist
0,123  0,029  Topoisomerase II alpha inhibitor
0,169  0,077  Phobic disorders treatment
0,108  0,018  Narcotic antagonist
0,155  0,066  Antidiarrheal
0,101  0,011  Dopamine transporter inhibitor
0,115  0,030  Phosphodiesterase I inhibitor
0,203  0,118  Antiprotozoal (Trypanosoma)
0,181  0,100  Embryotoxic
0,107  0,026  mTOR complex 2 inhibitor
0,101  0,024  Calcium channel L-type blocker
0,158  0,082  UGT2B7 substrate
0,092  0,016  Glutamate (mGluR7) antagonist
0,192  0,116  Antineoplastic (renal cancer)
0,084  0,010  5 Hydroxytryptamine 2C agonist
0,091  0,020  5 Hydroxytryptamine 3 antagonist
0,098  0,027  5 Hydroxytryptamine uptake inhibitor
0,119  0,049  Nav1.1 sodium channel blocker
0,109  0,040  Carcinogenic, group 2A
0,267  0,198  Alzheimer's disease treatment
0,075  0,009  Factor III inhibitor
0,086  0,020  5 Hydroxytryptamine 6 antagonist
0,155  0,091  Aldehyde oxidase substrate
0,119  0,056  Sphingosine 1-phosphate receptor 2 agonist
0,066  0,005  Phosphodiesterase 6C inhibitor
0,099  0,037  Antiviral (Hepatitis A)
0,164  0,102  Clk dual-specificity kinase inhibitor
0,099  0,041  ATPase (Vacuolar H+) inhibitor
0,167  0,110  Proto-oncogene tyrosine-protein kinase Fyn inhibitor
0,059  0,005  Phosphodiesterase 6B inhibitor
0,087  0,033  Antidote, organophosphates
0,146  0,092  Cystic fibrosis treatment
0,077  0,025  Antiviral (Parainfluenza)
0,113  0,062  Activin receptor-like kinase 4 inhibitor
0,171  0,121  Antiprotozoal (Leishmania)
0,095  0,046  Tocolytic
0,200  0,152  12-Lipoxygenase inhibitor
0,084  0,036  Phosphodiesterase VI inhibitor
0,136  0,090  Heat shock protein 70 antagonist
0,072  0,027  Nicotinic neuronal receptor agonist
0,095  0,051  Histamine N-methyltransferase inhibitor
0,075  0,031  5 Hydroxytryptamine 3 agonist
0,124  0,081  Cocaine dependence treatment
0,168  0,126  Antineoplastic (cervical cancer)
0,219  0,177  Immunosuppressant
0,143  0,102  Nitric oxide antagonist
0,066  0,026  Nicotinic alpha7 receptor agonist
0,092  0,053  Acetylcholine agonist
0,058  0,019  Potassium channel small-conductance Ca-activated blocker
0,103  0,065  Expectorant
0,188  0,150  Antiepileptic
0,063  0,027  Melanin-concentrating hormone receptor 1 antagonist
0,064  0,028  Ryanodine receptor antagonist
0,125  0,089  Lipid peroxidase inhibitor
0,080  0,044  Glutamate decarboxylase inhibitor
0,049  0,014  Vesicle monoamine transporter inhibitor
0,046  0,011  Endothelin receptor antagonist
0,079  0,045  Antitreponemal
0,118  0,084  CNS active muscle relaxant
0,164  0,131  VEGF expression inhibitor
0,047  0,015  Opioid delta receptor agonist
0,109  0,077  Menstruation disorders treatment
0,036  0,005  Phosphodiesterase 6H inhibitor
0,036  0,005  Phosphodiesterase 6G inhibitor
0,192  0,162  Bone diseases treatment
0,071  0,042  Acetylcholine M5 receptor agonist
0,047  0,021  Dopamine D3 agonist
0,101  0,074  DOPA decarboxylase inhibitor
0,083  0,057  Antiprotozoal activity enhancer
0,034  0,008  Endothelin B receptor antagonist
0,117  0,091  Papain-like protease (SARS coronavirus) inhibitor
0,036  0,010  Nicotinic alpha4beta2 receptor agonist
0,058  0,032  Alpha tubulin antagonist
0,148  0,122  UGT1A1 substrate
0,061  0,038  Phosphodiesterase 1A inhibitor
0,037  0,013  Nicotinic alpha3beta4 receptor agonist
0,139  0,116  Sleep disorders treatment
0,104  0,081  Adenylate cyclase inhibitor
0,152  0,129  HERG channel blocker
0,219  0,198  Antiprotozoal
0,125  0,107  UGT1A3 substrate
0,028  0,010  Endothelin A receptor antagonist
0,114  0,097  Antifungal enhancer
0,069  0,052  Histidine decarboxylase inhibitor
0,156  0,139  NOS2 expression inhibitor
0,143  0,127  Antiviral (Hepatitis)
0,113  0,098  Attention deficit/hyperactivity disorder treatment
0,031  0,016  5 Hydroxytryptamine 6 agonist
0,189  0,175  5 Hydroxytryptamine uptake stimulant
0,025  0,012  Phosphodiesterase 6A inhibitor
0,122  0,110  MAP3K9 inhibitor
0,065  0,053  Premenstrual syndrome treatment
0,135  0,124  Platelet adhesion inhibitor
0,128  0,118  Melanin inhibitor
0,048  0,038  Dopamine D4 agonist
0,051  0,042  Alpha-mannosidase inhibitor
0,118  0,109  Antidote
0,130  0,123  Ca2+-transporting ATPase inhibitor
0,126  0,120  Pulmonary hypertension treatment
0,124  0,118  Carcinogenic
0,099  0,093  Microtubule formation inhibitor
0,037  0,032  5 Hydroxytryptamine 2B agonist
0,159  0,155  Antioxidant
0,026  0,023  HCV NS5A inhibitor
0,170  0,167  Amyotrophic lateral sclerosis treatment
0,019  0,017  Imidazoline I1 receptor antagonist
0,102  0,101  Cyclooxygenase 3 inhibitor
0,171  0,171  Radiosensitizer
0,018  0,018  Antibiotic Quinolone-like

